JENNIFER PATTON: Open Payments
NPI 1861163172 · WARREN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$686 in 35 payments from 9 companies in 2025. Trend: 2023 $311 · 2024 $411 · 2025 $686
Food & beverage: $686
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $206 |
| Orexo US, Inc. | 6 | $106 |
| Indivior Inc. | 3 | $95 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $74 |
| Otsuka America Pharmaceutical, Inc. | 3 | $67 |
| Braeburn Inc. | 3 | $65 |
| Exact Sciences Corporation | 2 | $36 |
| Amgen Inc. | 1 | $18 |
| Actelion Pharmaceuticals US, Inc. | 1 | $18 |
Products named: MAVYRET, Zubsolv, SUBLOCADE, VRAYLAR, CAPLYTA, REXULTI, BRIXADI, Cologuard Collection Kit.
Industry payments across MI — which companies pay providers there.
